We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.
TARO

Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

16 hedge funds and large institutions have $29.2M invested in Taro Pharmaceutical Industries Ltd. in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 82 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

83% less funds holding

Funds holding: 94 → 16 (-78)

85% less capital invested

Capital invested by funds: $200M → $29.2M (-$171M)

93% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 82

Holders
16
Holders Change
-78
Holders Change %
-82.98%
% of All Funds
0.23%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
6
Increased
4
Reduced
2
Closed
82
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
+$128K
2
KAM
Krensavage Asset Management
New York
+$94.3K
3
Osaic Holdings
Osaic Holdings
Arizona
+$8.45K
4
FFA
Farther Finance Advisors
California
+$5.05K
5
MPWT
MassMutual Private Wealth & Trust
Connecticut
+$3.23K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$26.1M
2
Renaissance Technologies
Renaissance Technologies
New York
-$24.2M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$22M
4
BIP
Brandes Investment Partners
California
-$12M
5
EP
Eversept Partners
New York
-$11.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
– -$3.37M -79,489 Closed
Arrowstreet Capital
27
Arrowstreet Capital
Massachusetts
– -$2.49M -58,888 Closed
Morgan Stanley
28
Morgan Stanley
New York
– -$2.37M -56,001 Closed
Northern Trust
29
Northern Trust
Illinois
– -$2.31M -54,603 Closed
M
30
Murchinson
Ontario, Canada
– -$2.29M -54,137 Closed
Vanguard Group
31
Vanguard Group
Pennsylvania
– -$2.27M -53,729 Closed
AIM
32
ARK Investment Management
Florida
– -$2.14M -50,446 Closed
N
33
Nuveen
North Carolina
– -$1.94M -45,865 Closed
Norges Bank
34
Norges Bank
Norway
– -$1.81M -42,835 Closed
UBS Group
35
UBS Group
Switzerland
– -$1.33M -31,317 Closed
Citadel Advisors
36
Citadel Advisors
Florida
– -$1.12M -26,469 Closed
Bank of New York Mellon
37
Bank of New York Mellon
New York
– -$950K -22,436 Closed
Squarepoint
38
Squarepoint
New York
– -$917K -21,656 Closed
CL
39
CSS LLC
Illinois
– -$887K -20,941 Closed
Charles Schwab
40
Charles Schwab
California
– -$791K -18,686 Closed
Swiss National Bank
41
Swiss National Bank
Switzerland
– -$788K -18,600 Closed
Invesco
42
Invesco
Georgia
– -$759K -17,917 Closed
MAM
43
Martingale Asset Management
Massachusetts
– -$689K -16,268 Closed
SC
44
Sagefield Capital
Texas
– -$665K -15,700 Closed
IA
45
Inspire Advisors
Idaho
– -$614K -14,495 Closed
Balyasny Asset Management
46
Balyasny Asset Management
Illinois
– -$569K -13,444 Closed
YCM
47
Yakira Capital Management
Connecticut
– -$566K -13,359 Closed
PCM
48
PenderFund Capital Management
British Columbia, Canada
– -$734K -12,800 Closed
JP Morgan Chase
49
JP Morgan Chase
New York
– -$528K -12,477 Closed
SO
50
STRS Ohio
Ohio
– -$521K -12,300 Closed
1
2
3 4

TARO Hedge Fund Activity: Q2 2024 in Review

16 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q2 2024, worth a combined $29.2M — down 85% from $200M a quarter earlier.

Sellers outnumbered buyers: 82 funds closed out of TARO and 6 opened new positions — a net loss of 76 holders — while 2 trimmed existing stakes and 4 added.

The largest buyer was RhumbLine Advisers, adding an estimated $128K. The largest seller was BlackRock, exiting entirely with an estimated $26.1M sold.

  • 16 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q2 2024, down from 94 in Q1 2024.
  • Funds reported $29.2M of Taro Pharmaceutical Industries Ltd. stock for Q2 2024, down 85% quarter-over-quarter.
  • 6 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q2 2024 and 82 closed out, a net change of -76 holders.
  • The largest Taro Pharmaceutical Industries Ltd. buyer in Q2 2024 was RhumbLine Advisers, an estimated $128K added.
  • The largest Taro Pharmaceutical Industries Ltd. seller in Q2 2024 was BlackRock, an estimated $26.1M sold.

Based on aggregated 13F filings for Q2 2024.